First Over-the-Counter Birth Control Pill Approved by FDA
On July 13, 2023, the U.S. Food and Drug Administration (FDA) approved the first ever non-prescription birth control pill. The progestin-only oral contraceptive known as Opill (norgestrel) is expected to be available in pharmacies, supermarkets, and convenience stores by early 2024. Opill claims a 93 percent efficacy rate in pregnancy prevention.1 Norgestrel Originally Approved in […]
More Evidence SARS CoV-2 Escaped from Chinese Laboratory
U.S. government officials have admitted that the first patients infected with the SARS-CoV-2 virus were researchers working at the Wuhan Institute of Virology (WIV) in China, despite claims by former director of the U.S. National Institute of Allergy and Infectious Disease (NIAID) Anthony Fauci, MD that “we may never know” the true origin of the […]
FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
More Women Bearing the Brunt of COVID Vaccine Reactions and Injury
Early reports to the Vaccine Adverse Event Reporting System (VAERS), a centralized federally operated vaccine reaction reporting system, after the messenger RNA (mRNA) COVID-19 shots were distributed under an Emergency Use Authorization (EUA in the United States revealed that women were reported to have experienced more severe allergic reactions to the COVID-19 shots than men. […]
U.S. Government Pockets $400 Million from Moderna mRNA COVID Shots
A recently disclosed contract reveals that the U.S. government received millions of dollars in licensing fees from Moderna, Inc. The company paid the National Institutes of Health (NIH) $400 million to use NIH’s spike protein technology in Moderna’s Spikevax messenger RNA (mRNA) COVID-19 biologic.1 2 The large payment was part of a royalty-bearing license agreement […]